Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temporary interruption of adjuvant endocrine therapy to allow pregnancy in young women with hormone receptor-positive breast cancer
NL-OMON42456Recruiting
- Sponsor
- IBCSG Coordinating Center
- Start
- Nov 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial in breast cancer, sponsored by IBCSG Coordinating Center. Primary endpoint: Breast cancer free interval. Started Nov 2016; status: recruiting.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON42456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42456.